Table 1.
Parameter | Mean (SD) NT (N = 31) |
Mean (SD) ASD (N = 34) |
p-value |
---|---|---|---|
Sex (male/female) | 19/12 | 21/13 | > .999# |
Age in years | 35 (10) | 35 (10) | .963 |
IQ (MWT-B) | 107 (11) | 111 (16); Na = 1 | .434 |
SRS-2 | 32 (13) | 104 (27); Na = 2 | < .001 |
AQ | 12 (4) | 34 (8); Na = 2 | < .001 |
EQ | 49 (11) | 23 (12) | < .001 |
BDI-II | 3 (3) | 18 (13) | < .001 |
WURS-k | 12 (9) | 28 (15) | < .001 |
Psychiatric medication (yes/no) | 0/31 | 20/14 |
Group comparisons based on Fishers-Exact- (#) and Wilcoxon-Tests
ASD autism spectrum disorder; AQ Autism Spectrum Quotient (Baron-Cohen et al., 2001); BDI-II Beck Depression Inventory II (Beck et al., 1996; Hautzinger et al., 2006); EQ Empathy quotient (Baron-Cohen & Wheelwright, 2004); N number; NT neurotypical adults; IQ intelligence quotient; MWT-B Multiple choice vocabulary test (Lehrl et al., 1995); SRS-2 Social Responsiveness Scale 2 (Constantino, 2012); SD standard deviation; WURS-k Wender Utah Rating Scale (Retz-Junginger et al., 2002)